Compounds > triazoles
Page last updated: 2024-08-24

triazoles and Leukemia, Myelomonocytic, Acute

triazoles has been researched along with Leukemia, Myelomonocytic, Acute in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andrey, DO; Chalandon, Y; Emonet, S; Erard, V; Kaiser, L; van Delden, C1
Fujita, Y; Fukushima, T; Hirose, Y; Iwao, H; Kawabata, H; Masaki, Y; Miki, M; Nakajima, A; Nakamura, T; Sakai, T; Sawaki, T; Tanaka, M; Umehara, H1
Bacigalupo, A; Ferrua, MT; Gallamini, A; Ghirardo, D; Lo Nigro, C; Mattei, D; Mordini, N; Osenda, M; Viscoli, C1
Alaggio, R; Cecchetto, G; Cesaro, S; Cusinato, R; Pillon, M; Rigobello, L; Strugo, L; Zanesco, L1
Bilger, K; D'incan, E; Damaj, G; Doglio, MF; Faucher, C; Gastaut, JA; Ivanov, V; Le Brigand, B; Vey, N1
Akçali, Z; Boğa, S; DemIrhan, B; Karakuş, S; Sahin, FI; Yilmaz, Z1

Other Studies

6 other study(ies) available for triazoles and Leukemia, Myelomonocytic, Acute

ArticleYear
Cerebral Rhizomucor Infection Treated by Posaconazole Delayed-Release Tablets in an Allogeneic Stem Cell Transplant Recipient.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2017, Volume: 55

    Topics: Adult; Antifungal Agents; Delayed-Action Preparations; Fatal Outcome; Female; Humans; Immunocompromised Host; Leukemia, Myelomonocytic, Acute; Mucormycosis; Rhizomucor; Stem Cell Transplantation; Tablets; Transplantation, Homologous; Triazoles

2017
Iron chelation therapy with deferasirox induced complete remission in a patient with chemotherapy-resistant acute monocytic leukemia.
    Anticancer research, 2011, Volume: 31, Issue:5

    Topics: Aged; Aminoglycosides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzoates; Chelation Therapy; Deferasirox; Drug Resistance, Neoplasm; Erythrocyte Transfusion; Gemtuzumab; Humans; Iron Chelating Agents; Leukemia, Myelomonocytic, Acute; Male; Remission Induction; Salvage Therapy; Treatment Outcome; Triazoles

2011
Voriconazole in the management of invasive aspergillosis in two patients with acute myeloid leukemia undergoing stem cell transplantation.
    Bone marrow transplantation, 2002, Volume: 30, Issue:12

    Topics: Adult; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Daunorubicin; Deoxycholic Acid; Drug Combinations; Drug Resistance, Fungal; Etoposide; Fatal Outcome; Humans; Immunocompromised Host; Itraconazole; Leukemia, Megakaryoblastic, Acute; Leukemia, Myelomonocytic, Acute; Liposomes; Lung Diseases, Fungal; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pyrimidines; Recurrence; Remission Induction; Salvage Therapy; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Triazoles; Voriconazole

2002
Voriconazole for invasive aspergillosis in oncohematological patients: a single-center pediatric experience.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2003, Volume: 11, Issue:11

    Topics: Adolescent; Amphotericin B; Anemia, Aplastic; Anemia, Refractory; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Bone Marrow Transplantation; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hematologic Neoplasms; Humans; Leukemia, Myelomonocytic, Acute; Male; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Voriconazole

2003
Rapid improvement of disseminated aspergillosis with caspofungin/voriconazole combination in an adult leukemic patient.
    Annals of hematology, 2004, Volume: 83, Issue:6

    Topics: Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Leukemia, Myelomonocytic, Acute; Lipopeptides; Male; Middle Aged; Peptides; Peptides, Cyclic; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole

2004
t(8;16) AML developed subsequent to breast cancer therapy.
    Hematology (Amsterdam, Netherlands), 2006, Volume: 11, Issue:3

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Chromosomes, Human, Pair 16; Chromosomes, Human, Pair 8; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Estrogens; Fatal Outcome; Female; Fluorouracil; Humans; Idarubicin; Leukemia, Myelomonocytic, Acute; Mastectomy, Modified Radical; Middle Aged; Neoplasms, Hormone-Dependent; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Nitriles; Radiotherapy, Adjuvant; Translocation, Genetic; Triazoles

2006